Documents
Application Sponsors
ANDA 204393 | PIRAMAL CRITICAL | |
Marketing Status
Prescription | 001 |
Prescription | 002 |
Application Products
001 | INJECTABLE;INJECTION | 10MG/ML | 0 | MITIGO | MORPHINE SULFATE |
002 | INJECTABLE;INJECTION | 25MG/ML | 0 | MITIGO | MORPHINE SULFATE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2018-07-16 | |
Submissions Property Types
TE Codes
001 | Prescription | AP |
002 | Prescription | AP |
CDER Filings
PIRAMAL CRITICAL
cder:Array
(
[0] => Array
(
[ApplNo] => 204393
[companyName] => PIRAMAL CRITICAL
[docInserts] => ["",""]
[products] => [{"drugName":"MITIGO","activeIngredients":"MORPHINE SULFATE","strength":"10MG\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"MITIGO","activeIngredients":"MORPHINE SULFATE","strength":"25MG\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"07\/16\/2018","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2018\\\/204393Orig1s000ltr.pdf\"}]","notes":"> Label is not available on this site."}]
[supplements] => [{"actionDate":"05\/06\/2021","submission":"SUPPL-1","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."}]
[actionDate] => 2021-05-06
)
)